P3NET is not a company. P3NET is a unique alliance between academic research groups, aiming to deliver integrated services to support antimicrobial drug development.
P3NET is affiliated with ECRAID, which offers a well aligned international clinical trial infrastructure for infectious diseases.
Department of Clinical Pharmacology, Medical University of Vienna (AT) (website)
The department of Clinical Pharmacology at the Medical University of Vienna, headed by Prof. Markus Zeitlinger, is one of the most renowned institutes in the field of clinical pharmacology in Europe. Strong expertise in the designing and conduct, and evaluation of clinical trials in healthy volunteers and patients is available. Prof. Zeitlinger is a recognized expert on antimicrobial PK/PD. He is scientific adviser to the EMA and holds a range of positions in international societies in the field of infectious diseases and clinical pharmacology.
Department of Pharmacology and Toxicology, Radboud University Medical Center (NL) (website)
The department of Pharmacology and Toxicology at the Radboud University Medical Center (NL) is specialized in preclinical and clinical antimicrobial drug development. Prof. Brüggemann is specialized in antifungal and antibacterial pharmacology. The department has dedicated infrastructure and expertise bioanalytical assays for antimicrobials.
Leiden Academic Centre for Drug Research, Leiden University (NL) (website)
The Quantitative Pharmacology group at the Leiden Academic Centre for Drug Research and Leiden University (NL) led by Coen van Hasselt is specialized in antimicrobial pharmacometrics and mathematical PK/PD modeling strategies to support preclinical and clinical drug drug development. Furthermore, the group has extensive in vitro PK/PD capabilities.